Advanced visualization software developer Imaging Biometrics has received U.S. Food and Drug Administration 510(k) clearance for IB Clinic, a postprocessing perfusion, diffusion, and image analysis toolkit.
IB Clinic consists of three software modules: IB Neuro, IB Diffusion, and IB Delta Suite. These modules accept DICOM image sets from common scanner modalities and generate various perfusion and diffusion-related parameters and image intensity differences, according to the company.
IB Clinic is designed to enhance the process to make advanced image assessment, treatment consideration, and monitoring of therapeutic response, Imaging Biometrics said. IB Neuro accepts both MRI dynamic susceptibility contrast and CT perfusion datasets and performs data postprocessing to help confirm decisions related to perfusion imaging of brain tumors and other brain disorders, according to the company.
IB Delta Suite generates maps of the differences in image intensity on a voxel-by-voxel basis for two images acquired at different times or from different scanners, the company said.
